GENE ONLINE|News &
Opinion
Blog

Deals
Funding
MorphoSys Partners with Royalty Pharma to Fund $1.7B Constellation Pharmaceuticals Buyout
2021-06-05
COVID-19 mRNA Vaccine
China’s mRNA Vaccine Developer Stemirna Secures $200 Million in New Funding
2021-06-04
Licensing
Bristol-Myers Faces Lawsuit Claims Over Side-Stepping $6.4 Billion CVR Payment
2021-06-04
R&D Atopic Dermatitis
Amgen, Kyowa Kirin Renew Long-Standing Partnership to Promote Atopic Dermatitis Therapy
2021-06-02
Funding Series A Funding
Singapore’s Esco Secures $200M in Oversubscribed Series A to Develop Cell and Gene Therapy Equipments
2021-05-28
Deals Respiratory Disease
Pieris Pharma Teams up With Genentech to Take On the Respiratory and Ophthalmology Markets
2021-05-26
M&A
Xeris to Snag Bucks County-based Strongbridge Biopharma for $267 Million
2021-05-25
Manufacturing Gene Therapy
Biogen Inks $120 Million Pact with High Flying Ginkgo Bioworks to Redefine Manufacturing of Gene Therapy Vectors
2021-05-23
Technology AI
Exscientia Signs $1 Billion Worth AI Deal to Boost BMS’ Drug Discovery Pipeline
2021-05-21
Asia-Pacific
WuXi Biologics and WuXi STA Establish Joint Venture to Advance Bioconjugates
2021-05-17
IPO SPAC
Ginkgo Bioworks to Go Public Via a Colossal SPAC Deal Valued at $17.5 Billion
2021-05-12
M&A
CrownBio Acquires Dutch CRO to Expand In Vitro Services Portfolio
2021-05-07
Funding Series C Funding
Oculis Raises $50 Million to Push Ophthalmic Portfolio and Expand International Foothold
2021-05-06
IPO SPAC
Swiss Biotech Roivant Sciences Enters Wall Street with a $611 Million SPAC Merger
2021-05-06
M&A Pfizer
Pfizer Expands in Infectious Disease Market with Amplyx’s Acquisition
2021-05-03
1 … 32 33 34 35 36 … 47
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top